• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咪唑并[1,2 - a]吡啶:一种高效治疗剂可在体外清除梨形虫感染。

Imidazo[1,2-a]pyridine: a Highly Potent Therapeutic Agent Clears Piroplasm Infection In Vitro.

作者信息

Rizk Mohamed Abdo, El-Sayed Shimaa Abd El-Salam, El-Alfy El-Sayed, Igarashi Ikuo

机构信息

National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro, Hokkaido, 080-8555, Japan.

Department of Internal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516, Egypt.

出版信息

Acta Parasitol. 2023 Mar;68(1):249-256. doi: 10.1007/s11686-022-00655-w. Epub 2023 Jan 13.

DOI:10.1007/s11686-022-00655-w
PMID:36637693
Abstract

BACKGROUND AND PURPOSE

The imidazo[1,2-a] pyridines have huge applications in medicinal chemistry with potent activity against wide spectrum of infectious agents. The efficacy of imidazo[1,2-a]pyridine on the in vitro growth of different piroplasms, including Babesia bovis, B. bigemina, B. divergens, B. caballi, and Theileria equi, was investigated in this study.

METHODS

The anti-piroplasm efficacy of imidazo[1,2-a] pyridines was assessed using a fluorescence-based SYBR Green I assay. Furthermore, efficacy of imidazo[1,2-a]pyridine against piroplasms following discontinuation of treatment was also assessed using a viability assay. In vitro cultures of B. bovis and T. equi were used to assess the imidazo[1,2-a]pyridine and diminazene aceturate (DA) interaction.

RESULTS

In vitro, imidazo[1,2-a]pyridine inhibited the growth of B. bovis, B. bigemina, B. caballi, and T. equi in a dose-dependent manner. The highest inhibitory effects of imidazo[1,2-a]pyridine were detected on the growth of B. caballi with IC value of 0.47 ± 0.07. Interestingly, the efficacy of imidazo[1,2-a]pyridine was higher against B. bigemina (IC: 1.37 ± 0.15) compared to the positive-control DA (IC: 2.29 ± 0.06). The viability test findings indicate that imidazo[1,2-a]pyridine had a long-lasting inhibitory effect on bovine Babesia parasites in vitro growth up to 4 days after treatment. Notably, when coupled with DA at 0.75 or 0.50 IC, a high concentration (0.75 IC) of imidazo[1,2-a]pyridine produced additive suppression of B. bovis growth which suggest that imidazo[1,2-a]pyridine/DA could be a promising combination therapy for the treatment of B. bovis.

CONCLUSION

The obtained encouraging findings pave the way for in vitro and in vivo efficacy trials of imidazo[1,2-a]pyridine derivatives against several piroplasmids.

摘要

背景与目的

咪唑并[1,2 - a]吡啶在药物化学领域有广泛应用,对多种感染因子具有强大活性。本研究考察了咪唑并[1,2 - a]吡啶对不同梨形虫体外生长的效果,这些梨形虫包括牛巴贝斯虫、双芽巴贝斯虫、分歧巴贝斯虫、马巴贝斯虫和驽巴贝斯虫。

方法

采用基于荧光的SYBR Green I检测法评估咪唑并[1,2 - a]吡啶的抗梨形虫效果。此外,还通过活力检测评估了停药后咪唑并[1,2 - a]吡啶对梨形虫的疗效。利用牛巴贝斯虫和驽巴贝斯虫的体外培养物评估咪唑并[1,2 - a]吡啶与乙酰马啉(DA)的相互作用。

结果

在体外,咪唑并[1,2 - a]吡啶以剂量依赖方式抑制牛巴贝斯虫、双芽巴贝斯虫、马巴贝斯虫和驽巴贝斯虫的生长。咪唑并[1,2 - a]吡啶对马巴贝斯虫生长的抑制作用最强,IC值为0.47±0.07。有趣的是,与阳性对照DA(IC:2.29±0.06)相比,咪唑并[1,2 - a]吡啶对双芽巴贝斯虫的疗效更高(IC:1.37±0.15)。活力测试结果表明,咪唑并[1,2 - a]吡啶在治疗后长达4天对牛巴贝斯虫寄生虫的体外生长具有持久的抑制作用。值得注意的是,当与0.75或0.50 IC的DA联合使用时,高浓度(0.75 IC)的咪唑并[1,2 - a]吡啶对牛巴贝斯虫生长产生相加抑制作用,这表明咪唑并[1,2 - a]吡啶/DA可能是治疗牛巴贝斯虫的一种有前景的联合疗法。

结论

所获得的令人鼓舞的结果为咪唑并[1,2 - a]吡啶衍生物针对多种梨形虫的体外和体内疗效试验铺平了道路。

相似文献

1
Imidazo[1,2-a]pyridine: a Highly Potent Therapeutic Agent Clears Piroplasm Infection In Vitro.咪唑并[1,2 - a]吡啶:一种高效治疗剂可在体外清除梨形虫感染。
Acta Parasitol. 2023 Mar;68(1):249-256. doi: 10.1007/s11686-022-00655-w. Epub 2023 Jan 13.
2
Ascorbic acid co-administration with a low dose of diminazene aceturate inhibits the in vitro growth of Theileria equi, and the in vivo growth of Babesia microti.抗坏血酸与低剂量乙酰苯肼联合给药抑制马媾疫锥虫的体外生长和巴贝斯虫微孢子虫的体内生长。
Parasitol Int. 2022 Oct;90:102596. doi: 10.1016/j.parint.2022.102596. Epub 2022 May 6.
3
Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites.疟疾风险投资病原体盒筛选抗梨形虫寄生虫。
Int J Parasitol Drugs Drug Resist. 2019 Aug;10:84-90. doi: 10.1016/j.ijpddr.2019.06.004. Epub 2019 Jun 19.
4
Endochin-like quinolone-300 and ELQ-316 inhibit Babesia bovis, B. bigemina, B. caballi and Theileria equi.内啡肽样喹诺酮-300 和 ELQ-316 抑制牛巴贝斯虫、双芽巴贝斯虫、马巴贝斯虫和马媾疫锥虫。
Parasit Vectors. 2020 Dec 3;13(1):606. doi: 10.1186/s13071-020-04487-3.
5
The effects of trans-chalcone and chalcone 4 hydrate on the growth of Babesia and Theileria.反式二氢查耳酮和 4 水合查耳酮对巴贝西虫和泰勒虫生长的影响。
PLoS Negl Trop Dis. 2019 May 24;13(5):e0007030. doi: 10.1371/journal.pntd.0007030. eCollection 2019 May.
6
In Vitro Inhibitory Effects and Bioinformatic Analysis of Norfloxacin and Ofloxacin on Piroplasm.诺氟沙星和氧氟沙星对梨形虫的体外抑制作用及生物信息学分析
Acta Parasitol. 2023 Mar;68(1):213-222. doi: 10.1007/s11686-022-00648-9. Epub 2022 Dec 21.
7
Evaluation of the in vitro and in vivo inhibitory effect of thymoquinone on piroplasm parasites.评价百里醌对梨形虫寄生虫的体外和体内抑制作用。
Parasit Vectors. 2019 Jan 16;12(1):37. doi: 10.1186/s13071-019-3296-z.
8
17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice.17-DMAG 抑制几种巴贝虫物种和马媾疫锥虫在体外培养物中的增殖,以及微小巴贝斯虫在小鼠中的增殖。
Int J Parasitol Drugs Drug Resist. 2018 Apr;8(1):104-111. doi: 10.1016/j.ijpddr.2018.02.005. Epub 2018 Mar 1.
9
Antiparasitic activity of FLLL-32 against four species, , , and , and one species, , and in mice.FLLL-32对小鼠体内四种疟原虫(具体虫种未给出)以及一种利什曼原虫(具体虫种未给出)的抗寄生虫活性。
Front Pharmacol. 2023 Nov 2;14:1278451. doi: 10.3389/fphar.2023.1278451. eCollection 2023.
10
Evaluation of the and inhibitory effects of against the growth of piroplasm parasites.评估[具体物质名称]对梨形虫寄生虫生长的[具体作用]和抑制作用。 (注:原文中“the and inhibitory effects”表述不完整,有缺失信息)
J Adv Vet Anim Res. 2022 Jun 26;9(2):267-274. doi: 10.5455/javar.2022.i592. eCollection 2022 Jun.

引用本文的文献

1
Antiparasitic activity of FLLL-32 against four species, , , and , and one species, , and in mice.FLLL-32对小鼠体内四种疟原虫(具体虫种未给出)以及一种利什曼原虫(具体虫种未给出)的抗寄生虫活性。
Front Pharmacol. 2023 Nov 2;14:1278451. doi: 10.3389/fphar.2023.1278451. eCollection 2023.

本文引用的文献

1
Current and Future Molecular Diagnostics of Tick-Borne Diseases in Cattle.牛蜱传疾病的当前及未来分子诊断方法
Vet Sci. 2022 May 21;9(5):241. doi: 10.3390/vetsci9050241.
2
Identification and Characterization of P0 Protein as a Vaccine Candidate Against , Blood Parasite of Veterinary and Zoonotic Importance.鉴定和表征P0蛋白作为一种针对具有兽医和人畜共患病重要性的血液寄生虫的候选疫苗。
Front Vet Sci. 2022 Jan 7;8:795906. doi: 10.3389/fvets.2021.795906. eCollection 2021.
3
Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of , a Blood-Borne Parasite of Veterinary and Zoonotic Importance.
药用疟疾风险基金库中的化合物抑制血源性寄生虫的体外生长,这种寄生虫对兽医和人畜共患病具有重要意义。
Molecules. 2021 Nov 24;26(23):7118. doi: 10.3390/molecules26237118.
4
Evaluation of the inhibitory effect of Zingiber officinale rhizome on Babesia and Theileria parasites.评价姜根茎对巴贝斯虫和泰勒虫寄生虫的抑制作用。
Parasitol Int. 2021 Dec;85:102431. doi: 10.1016/j.parint.2021.102431. Epub 2021 Aug 2.
5
Collaborative virtual screening to elaborate an imidazo[1,2-]pyridine hit series for visceral leishmaniasis.开展协作虚拟筛选以精心打造用于内脏利什曼病的咪唑并[1,2 - ]吡啶活性系列化合物。
RSC Med Chem. 2021 Jan 21;12(3):384-393. doi: 10.1039/d0md00353k.
6
Protein Kinases: Important Regulators of the Parasite Life Cycle and Molecular Targets for Treating Leishmaniasis.蛋白激酶:寄生虫生命周期的重要调节因子及治疗利什曼病的分子靶点
Microorganisms. 2021 Mar 27;9(4):691. doi: 10.3390/microorganisms9040691.
7
Assay methods for in vitro and in vivo anti-Babesia drug efficacy testing: Current progress, outlook, and challenges.用于体外和体内抗巴贝虫药物功效测试的分析方法:当前的进展、展望和挑战。
Vet Parasitol. 2020 Mar;279:109013. doi: 10.1016/j.vetpar.2019.109013. Epub 2019 Dec 13.
8
Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: A review.通过重新利用疟疾药箱发现针对巴贝西虫和泰勒虫属寄生虫的体外有效抑制剂:综述。
Vet Parasitol. 2019 Oct;274:108895. doi: 10.1016/j.vetpar.2019.07.003. Epub 2019 Jul 19.
9
A Review on Equine Piroplasmosis: Epidemiology, Vector Ecology, Risk Factors, Host Immunity, Diagnosis and Control.马焦虫病综述:流行病学、媒介生态学、危险因素、宿主免疫、诊断与控制。
Int J Environ Res Public Health. 2019 May 16;16(10):1736. doi: 10.3390/ijerph16101736.
10
Drug repurposing for antimicrobial discovery.药物重用以发现抗菌药物。
Nat Microbiol. 2019 Apr;4(4):565-577. doi: 10.1038/s41564-019-0357-1. Epub 2019 Mar 4.